Normal view MARC view ISBD view

Strategies for preventing occupational exposure to potent compounds. [electronic resource]

By:

Calhoun, Dean M

Contributor(s):

Producer: 20110512Description: 93-6 p. digitalISSN:

1537-6524

Subject(s):

Online resources:

Available from publisher's website

In: Toxicology mechanisms and methods vol. 21

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

3841 Human interleukin 1.
by Krakauer, T
3842 Signal transduction by the IL-1 type I receptor: evidence for the involvement of a receptor-coupled protein kinase.
by Martin, M
3843 Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential.
by Lauffer, L
3844 Cytokine-mediated regulation of type IV collagenase expression and production in human trophoblast cells.
by Shimonovitz, S
3845 Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10.
by Doughty, L A
3846 Interleukin-1 receptor blockade attenuates oxygen-derived free radical production and microcirculatory disturbances in ischemia/reperfusion injury in the liver.
by Shirasugi, N
3847 Endotoxin impedes vasoconstriction in the spleen: role of endogenous interleukin-1 and sympathetic innervation.
by Rogausch, H
3848 The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome.
by Donnelly, S C
3849 Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer.
by Hunter, C A
3850 Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.
by Horai, R
3851 Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
by Ito, H
3852 Structure and function of Toll-like receptor proteins.
by Means, T K
3853 Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: evidence for involvement of an interleukin-1beta193-195 receptor antagonism in the alveolar epithelium.
by Haddad, J J
3854 A randomized controlled trial of interleukin-1 receptor antagonist in a rabbit model of ascending infection in pregnancy.
by McDuffie, R S
3855 Interleukin-1 beta, but not IL-1 alpha, mediates nerve growth factor secretion from rat astrocytes via type I IL-1 receptor.
by Juric, D M
3856 [Receptors and signal proteins of the innate immune system as new targets in sepsis therapy. Reprogramming of the immune response].
by Holzmann, B
3857 [Therapeutic use of "biologics" in inflammatory joint and spinal diseases].
by Seitz, M
3858 The epistatic interrelationships of IL-1, IL-1 receptor antagonist, and the type I IL-1 receptor.
by Irikura, Vera M
3859 Cytokine release by lipopolysaccharide-stimulated whole blood from patients with typhoid fever.
by House, Deborah
3860 The roles of interleukin-1 and interleukin-1 receptor antagonist in antigen-specific immune responses.
by Lin, Kai-Wei